A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor ($ MTGI^{™} $), in patients with advanced solid tumours (Englisch)
- Neue Suche nach: Scott, Edwina N.
- Neue Suche nach: Thomas, Anne L.
- Neue Suche nach: Molife, L. Rhoda
- Neue Suche nach: Ahmed, Samreen
- Neue Suche nach: Blagden, Sarah
- Neue Suche nach: Fong, Peter C.
- Neue Suche nach: Kowal, Kristin
- Neue Suche nach: McCoy, Candice
- Neue Suche nach: Wiesinger, Herbert
- Neue Suche nach: Steward, Will
- Neue Suche nach: De Bono, Johann
- Neue Suche nach: Scott, Edwina N.
- Neue Suche nach: Thomas, Anne L.
- Neue Suche nach: Molife, L. Rhoda
- Neue Suche nach: Ahmed, Samreen
- Neue Suche nach: Blagden, Sarah
- Neue Suche nach: Fong, Peter C.
- Neue Suche nach: Kowal, Kristin
- Neue Suche nach: McCoy, Candice
- Neue Suche nach: Wiesinger, Herbert
- Neue Suche nach: Steward, Will
- Neue Suche nach: De Bono, Johann
In:
Cancer Chemotherapy and Pharmacology
;
64
, 2
; 425-429
;
2009
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor ($ MTGI^{™} $), in patients with advanced solid tumours
-
Beteiligte:Scott, Edwina N. ( Autor:in ) / Thomas, Anne L. ( Autor:in ) / Molife, L. Rhoda ( Autor:in ) / Ahmed, Samreen ( Autor:in ) / Blagden, Sarah ( Autor:in ) / Fong, Peter C. ( Autor:in ) / Kowal, Kristin ( Autor:in ) / McCoy, Candice ( Autor:in ) / Wiesinger, Herbert ( Autor:in ) / Steward, Will ( Autor:in )
-
Erschienen in:Cancer Chemotherapy and Pharmacology ; 64, 2 ; 425-429
-
Verlag:
- Neue Suche nach: Springer-Verlag
- Neue Suche nach: Springer
-
Erscheinungsort:Berlin
-
Erscheinungsdatum:2009
-
ISSN:
-
ZDBID:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
- Neue Suche nach: 44.40 / 44.38
- Weitere Informationen zu Basisklassifikation
-
Schlagwörter:
-
Klassifikation:
-
Datenquelle:
Inhaltsverzeichnis – Band 64, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 223
-
Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cellsSuzuki, Maiko / Shinohara, Fumiaki / Endo, Manabu / Sugazaki, Masaki / Echigo, Seishi / Rikiishi, Hidemi et al. | 2008
- 233
-
Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patientsSpecenier, Pol M. / Ciuleanu, Tudor / Latz, Jane E. / Musib, Luna C. / Darstein, Christelle L. S. / Vermorken, Jan B. et al. | 2008
- 253
-
Enhancement of the in vivo antitumor activity of clofarabine by 1-β-d-[4-thio-arabinofuranosyl]-cytosineParker, William B. / Shaddix, Sue C. / Gilbert, Karen S. / Shepherd, Rodney V. / Waud, William R. et al. | 2008
- 263
-
Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimusBoni, Joseph / Abbas, Richat / Leister, Cathie / Burns, Jaime / Jordan, Ronald / Hoffmann, Matthew / DeMaio, William / Hug, Bruce et al. | 2008
- 279
-
Protein nitration, PARP activation and NAD+ depletion may play a critical role in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis in the ratAbraham, Premila / Rabi, Suganthy et al. | 2008
- 287
-
Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignanciesMita, Monica / Mita, Alain / Sarantopoulos, John / Takimoto, Chris H. / Rowinsky, Eric K. / Romero, Ofelia / Angiuli, Patrizia / Allievi, Cecilia / Eisenfeld, Amy / Verschraegen, Claire F. et al. | 2008
- 297
-
Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding studyMäenpää, Johanna / Leminen, Arto et al. | 2008
- 301
-
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancerLorizzo, Katia / Fazio, Nicola / Radice, Davide / Boselli, Sabrina / Ariu, Leonardo / Zampino, Maria Giulia / Nolè, Franco / Magni, Elena / Ardito, Raffaele / Minchella, Ida et al. | 2008
- 307
-
Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitroConnolly, Kate / Mitter, Richard / Muir, Morwenna / Jodrell, Duncan / Guichard, Sylvie et al. | 2008
- 317
-
Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II studyLee, Kyung Hee / Kim, Min Kyoung / Kim, Yeol Hong / Ryoo, Baek Yeol / Lim, Ho Yeong / Song, Hong Suk / Kim, Hoon Kyo / Lee, Myung Ah / Im, Seock Ah / Chang, Heung Moon et al. | 2008
- 335
-
Plasma and cerebrospinal fluid pharmacokinetics of tasidotin (ILX-651) and its metabolites in non-human primatesKilburn, Lindsay B. / Bonate, Peter L. / Blaney, Susan M. / McGuffey, Leticia / Nuchtern, Jed G. / Dauser, Robert / Thompson, Patrick / Gibson, Brian W. / Berg, Stacey L. et al. | 2008
- 341
-
Tau expression and efficacy of paclitaxel treatment in metastatic breast cancerTanaka, Satoru / Nohara, Takehiro / Iwamoto, Mitsuhiko / Sumiyoshi, Kazuhiro / Kimura, Kousei / Takahashi, Yuko / Tanigawa, Nobuhiko et al. | 2008
- 347
-
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancerKim, Kyoung Ha / Park, Young Suk / Chang, Myung Hee / Kim, Hyo Song / Jun, Hyun Jung / Uhm, Jieun / Yi, Seong Yoon / Lim, Do Hyoung / Ji, Sang Hoon / Park, Min Jae et al. | 2008
- 355
-
TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatinKim, Jong Gwang / Sohn, Sang Kyun / Chae, Yee Soo / Song, Hong Suk / Kwon, Ki-Young / Do, Young Rok / Kim, Min Kyoung / Lee, Kyung Hee / Hyun, Myung Soo / Lee, Won Sik et al. | 2008
- 361
-
Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanesIshida, Takanori / Kiba, Takayoshi / Takeda, Motohiro / Matsuyama, Kotone / Teramukai, Satoshi / Ishiwata, Ryota / Masuda, Norikazu / Takatsuka, Yuichi / Noguchi, Shinzaburo / Ishioka, Chikashi et al. | 2008
- 371
-
A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancerKim, Hyun Jung / Lee, Nam Su / Lee, Sang-Cheol / Bae, Sang Byung / Kim, Chan Kyu / Cheon, Young Gook / Kim, Young Seok / Moon, Jong Ho / Cho, Young Deok / Park, Sang Heum et al. | 2009
- 379
-
A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinomaRubio, Joaquín Casal / Vázquez, S. / Vázquez, F. / Amenedo, M. / Fírvida, J. L. / Mel, J. R. / Huidobro, G. / Álvarez, E. / Lázaro, M. / Alonso, G. et al. | 2009
- 385
-
Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancerLee, Gyeong-Won / Kang, Myung-Hee / Kim, Hoon-Gu / Kang, Jung Hun / Kim, Seok Hyun / Cho, Yu Ji / Jeong, Yi Yeong / Kim, Ho-Cheol / Lee, Jong Duk / Hwang, Young Sil et al. | 2008
- 399
-
Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapyTsavaris, Nicolas / Lazaris, Andreas / Kosmas, Christos / Gouveris, Panagiotis / Kavantzas, Nikolaos / Kopterides, Petros / Papathomas, Thomas / Agrogiannis, George / Zorzos, Haralambos / Kyriakou, Vassiliki et al. | 2009
- 401
-
Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trialSchmid, Peter / Krocker, J. / Kreienberg, R. / Klare, P. / Kittel, K. / Sommer, H. / Heinrich, G. / Steck, T. / Lichtenegger, W. / Elling, D. et al. | 2008
- 407
-
Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancerWaters, S. H. / Gillibrand, A. / Berry, H. / Kumar, S. / Velikova, G. / Dodwell, D. J. / Perren, Timothy J. et al. | 2009
- 419
-
The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cellsAscione, Alessandro / Cianfriglia, Maurizio / Dupuis, Maria Luisa / Mallano, Alessandra / Sau, Andrea / Pellizzari Tregno, Francesca / Pezzola, Silvia / Caccuri, Anna Maria et al. | 2009
- 425
-
A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor ($ MTGI^{™} $), in patients with advanced solid tumoursScott, Edwina N. / Thomas, Anne L. / Molife, L. Rhoda / Ahmed, Samreen / Blagden, Sarah / Fong, Peter C. / Kowal, Kristin / McCoy, Candice / Wiesinger, Herbert / Steward, Will et al. | 2009
- 431
-
Anthocyanins-based drugs for colon cancer treatment: the nutritionist’s point of viewGalvano, Fabio / Salamone, Federico / Nicolosi, Anna / Vitaglione, Paola et al. | 2009
-
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinomaGong, Youling / Ren, Li / Zhou, Lin / Zhu, Jiang / Huang, Meijuan / Zhou, Xiaojuan / Wang, Jin / Lu, You / Hou, Mei / Wei, Yuquan et al. | 2008
-
In vitro and in vivo study of an albumin-binding prodrug of doxorubicin that is cleaved by cathepsin BAbu Ajaj, Khalid / Graeser, Ralph / Fichtner, Iduna / Kratz, Felix et al. | 2009
-
Hydroxyurea and hydroxamic acid derivatives as antitumor drugsSaban, Nina / Bujak, Maro et al. | 2009
-
Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network studyThompson, Patrick A. / Rosner, Gary L. / Matthay, Katherine K. / Moore, Theodore B. / Bomgaars, Lisa R. / Ellis, Kenneth J. / Renbarger, Jamie / Berg, Stacey L. et al. | 2008
-
Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapyMomiyama, Kouichi / Nagai, Hidenari / Sumino, Yasukiyo et al. | 2008